Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Charts Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.07 USD +0.74% Intraday chart for Prelude Therapeutics Incorporated +9.41% -4.68%
Apr. 10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI
Apr. 10 Prelude Therapeutics Incorporated Announces Chief Financial Officer Changes CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bullish

Neutral

Resistance 4.610 5.630 5.690
Spread/Res.-11.71%-27.71%-28.47%
Spread/Supp.+18.31%+32.14%+124.86%
Support 3.440 3.080 1.810

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. Charts Prelude Therapeutics Incorporated